OB, G., J, S., E, G., L, R., & T, M. (2024). Personalized Versus Precision Nanomedicine for Treatment of Ovarian Cancer. Small (Weinheim an der Bergstrasse, Germany), 20(41), e2307462. https://doi.org/10.1002/smll.202307462
Chicago Style (17th ed.) CitationOB, Garbuzenko, Sapiezynski J, Girda E, Rodriguez-Rodriguez L, and Minko T. "Personalized Versus Precision Nanomedicine for Treatment of Ovarian Cancer." Small (Weinheim an Der Bergstrasse, Germany) 20, no. 41 (2024): e2307462. https://doi.org/10.1002/smll.202307462.
MLA (9th ed.) CitationOB, Garbuzenko, et al. "Personalized Versus Precision Nanomedicine for Treatment of Ovarian Cancer." Small (Weinheim an Der Bergstrasse, Germany), vol. 20, no. 41, 2024, p. e2307462, https://doi.org/10.1002/smll.202307462.